Webinar: Autoimmune-induced neuropsychiatric symptoms

How infections and autoimmune dysfunction can trigger neuropsychiatric symptoms

Infections disrupt immune system and impact the brain
Only test of its kind

Webinar Schedule

Friday, November 22 at 12pm CT

This presentation will review the biological process that occurs when infections trigger an immune dysfunction, impacting the brain and leading to the onset of various neurologic and psychiatric symptoms.

We will describe the signs and symptoms that may help identify whether an individual may be suffering from an autoimmune dysfunction versus a primary psychiatric disorder.

We will also review how the Autoimmune Brain Panel™ can assist in determining whether symptoms may be due to an autoimmune response and highlight several cases of patients who tested positive on the Panel and were successfully treated with a resolution in symptoms.

Webinar Presenter

Craig Shimasaki is President and CEO of Moleculera Biosciences, a neuroimmunology precision medicine company focused on identifying underlying roots of neurologic, psychiatric, and behavioral disorders triggered by an autoimmune response. He is a medical research scientist with over 35 years of translational development experience in biochemical interactions, molecular biology, viral pathogenesis and infection-triggered neuropsychiatric disorders.

Dr. Shimasaki has worked at all stages of research and development from bench to bedside. His research included epitope mapping of HIV proteins, genetic based risk predictors of breast cancer, influenza and RSV diagnostics and therapeutics and pathogenesis of infection triggered neuropsychiatric disorders. As a businessperson, he co-founded multiple companies and led multiple products through the FDA approval process and is a co-inventor on multiple patents.

Dr. Shimasaki started his career at Genentech. He received his BS in Biochemistry from University of California at Davis, his PhD in Molecular Biology from the University of Tulsa, and his MBA from Northwestern University, Kellogg School of Business. He is an Adjunct Professor at the University of Oklahoma where he teaches biotechnology entrepreneurship. His passion is to help translate scientific and medical discoveries into acutely needed products so that more patients can live healthier lives.